A detailed history of Ameriprise Financial Inc transactions in Arcellx, Inc. stock. As of the latest transaction made, Ameriprise Financial Inc holds 11,116 shares of ACLX stock, worth $976,318. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,116
Previous 11,310 1.72%
Holding current value
$976,318
Previous $624,000 48.72%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$50.91 - $86.61 $9,876 - $16,802
-194 Reduced 1.72%
11,116 $928,000
Q2 2024

Aug 14, 2024

SELL
$49.74 - $66.98 $145,887 - $196,452
-2,933 Reduced 20.59%
11,310 $624,000
Q1 2024

May 15, 2024

BUY
$51.85 - $73.49 $543,802 - $770,763
10,488 Added 279.31%
14,243 $990,000
Q4 2023

Feb 14, 2024

BUY
$31.75 - $57.99 $119,221 - $217,752
3,755 New
3,755 $208,000

Others Institutions Holding ACLX

About Arcellx, Inc.


  • Ticker ACLX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,819,200
  • Market Cap $3.85B
  • Description
  • Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company's lead ddCAR product candidate is CART-ddBCMA, which is in phase 1 clinical trial for the treatment of patients with relapsed or refractory (r/r) multiple myeloma (MM). It...
More about ACLX
Track This Portfolio

Track Ameriprise Financial Inc Portfolio

Follow Ameriprise Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.